• Sarepta Therapeutics' (SRPT) Buy Rating Reiterated at Needham & Company LLC

    Source: Buzz FX / 19 Mar 2025 13:06:16   America/Chicago


    Sarepta Therapeutics' (SRPT) Buy Rating Reiterated at Needham & Company LLC Written by MarketBeat March 19, 2025 Share Link copied to clipboard. Remove Ads Sarepta Therapeutics ( NASDAQ:SRPT - Get Free Report ) 's stock had its "buy" rating
    Read more...
Share on,